Ubtech Robotics Pivots to Consumers as JD.com Deal Broadens Its Humanoid Ambitions

Ubtech Robotics partners with JD.com for consumer humanoid sales, raises 2026 delivery outlook to 5,000 units amid 104% revenue growth.

The Chinese robotics group behind the Walker humanoid series is repositioning itself for the mass market, striking a retail partnership that marks a decisive shift away from its industrial roots. Ubtech Robotics and JD.com unveiled plans last Wednesday to develop and sell "ultra-bionic" humanoid robots through dedicated flagship stores across major Chinese cities, a move squarely aimed at affluent shoppers.

The agreement lands just days after management sharply raised its delivery outlook for the Walker S line. Instead of the previously guided 2,000 to 3,000 units, Ubtech now expects to ship 5,000 units in 2026. The upgraded forecast forms part of a broader effort to steer investor attention toward operational momentum rather than the persistent bottom-line losses.

Interim Results Show a Company Scaling Fast

The flurry of announcements rests on a set of half-year figures published in late August that showed revenue more than doubling. Sales climbed 104.1 percent to 1.27 billion renminbi in the first half of 2026, propelled by a 1,445 percent surge in full-body humanoid robot sales to 590.3 million renminbi. The net loss narrowed 23 percent to 339 million renminbi, while gross margin expanded by 9.7 percentage points to 44.7 percent.

A second reporting of the same period puts revenue at approximately 1,269.13 million yuan, a 104.2 percent increase from 621.46 million yuan a year earlier, with a net loss of 311.48 million yuan compared with 413.65 million yuan previously. Loss per share narrowed from 0.94 yuan to 0.62 yuan. The slight discrepancies between the two sets of figures reflect different accounting treatments, but the trajectory is consistent: explosive growth accompanied by improving, though still negative, profitability.

Consumer Push Gathers Pace

The consumer-facing UWORLD U1 companion robot series is showing early traction, with cumulative pre-orders surpassing 13,000 units. Ubtech is targeting production capacity of 50,000 units for the line by year-end, an ambitious goal that signals intent to graduate from niche player to volume manufacturer. The U1 builds on technology previously developed for Airbus and Texas Instruments, and within a single week the model attracted more than 2,100 pre-orders, according to the secondary report.

On the industrial side, the wheeled humanoid Cruzr Y1, equipped with a VLA model and Digua chips, targets enterprise customers. The company's product diversification comes as China accounts for roughly 90 percent of global humanoid robot shipments in the first half of 2026, according to industry estimates.

Incentives and Shareholder Alignment

An H-share incentive scheme for management and staff, formally approved at an extraordinary general meeting in Shenzhen last Wednesday, has been well received. The stock has gained 5.9 percent since the vote, suggesting investors view the alignment of management interests with those of shareholders favourably.

Competitive Pressures and Valuation Concerns

The recent tailwinds only partially offset the sector-wide nervousness that preceded them. The Shanghai initial public offering of rival Unitree Robotics in mid-August triggered a sell-off across Chinese robotics stocks as investors focused on the lack of near-term profitability among the major players. Unitree, which raised roughly 900 million US dollars and achieved a valuation of about 9 billion US dollars, saw its shares jump 460 percent on its first trading day. The company posted revenue of 11.52 million yuan, up 48.54 percent, with a net profit of 2.74 million yuan, though its gross margin declined to 56.0 percent amid rising research and distribution costs.

The two companies are heading in opposite financial directions: Ubtech grows faster but remains loss-making, while Unitree grows more slowly but is already profitable. That divergence is reflected in market valuations. Ubtech trades on the Hong Kong exchange at a price-earnings ratio of 13.6, a level considered demanding given the persistent losses.

Counterpoint Research ranks Ubtech as the world's fourth-largest humanoid robot maker, with a 4.4 percent share of global shipments in the first half of 2026 — a position that faces mounting pressure from domestic Chinese competitors.

Government Support and Technical Hurdles

State backing for the sector has intensified considerably. Chinese government funding for humanoid robotics reached 230 million US dollars in the first half of 2026, up from 62 million US dollars in the year-earlier period and just 6 million US dollars two years previously. Beijing targets production of more than 100,000 units in 2026, though Morgan Stanley's more conservative forecast puts the figure at 50,000 units.

A lingering concern, however, is operational performance. Reports indicate that Ubtech's Walker robots deployed at contract manufacturers such as BYD and Foxconn are achieving only 30 to 50 percent of human productivity — a reminder that impressive shipment numbers do not yet translate into full practical capability.

Market Position Remains Subdued

The shares closed Friday at 9.65 euros, up 4.7 percent on the day. The weekly gain stands at 3.8 percent and the monthly advance at 4.9 percent, yet the stock remains 33 percent lower since the start of the year and well below its 52-week high of 17.00 euros reached in January. The gap illustrates how far the valuation has retreated despite the operational progress.

Whether the combination of revenue growth, new partnerships, and raised delivery targets will be enough to restore investor confidence is the question hanging over the coming months.